Allurion Technologies, Inc. Increase (Decrease) in Accounts Receivable
Allurion Technologies, Inc. (ALUR) reported Increase (Decrease) in Accounts Receivable of -$365.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-05-15
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$365.00K, a 141.34% decline year-over-year.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.39M.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$865.00K.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was -$2.25M.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$844.00K.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$8.98M, a 781.11% decline from fiscal 2023.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $1.32M, a 94.22% decline from fiscal 2022.
- Allurion Technologies, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $22.82M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$365.00K 10-Q · filed 2026-05-15 | $1.02M derived: sum of 2 quarters · filed 2026-05-15 | $157.00K derived: sum of 3 quarters · filed 2026-05-15 | -$2.09M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $522.00K derived: sum of 2 quarters · filed 2026-03-30 | -$1.73M derived: sum of 3 quarters · filed 2026-03-30 | -$844.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$865.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$3.11M derived: sum of 2 quarters · filed 2025-11-17 | -$2.23M 10-Q · filed 2025-11-17 | -$4.01M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$1.37M 10-Q · filed 2025-08-19 | -$3.14M derived: sum of 3 quarters · filed 2026-05-15 | -$5.93M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $883.00K 10-Q · filed 2026-05-15 | -$895.00K derived: sum of 2 quarters · filed 2026-05-15 | -$3.68M derived: sum of 3 quarters · filed 2026-05-15 | -$6.42M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$4.57M derived: sum of 2 quarters · filed 2026-03-30 | -$7.30M derived: sum of 3 quarters · filed 2026-03-30 | -$8.98M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$2.79M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | -$5.53M derived: sum of 2 quarters · filed 2025-11-17 | -$7.20M 10-Q · filed 2025-11-17 | -$9.76M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$2.74M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$4.41M 10-Q/A · filed 2025-08-28 | -$6.98M derived: sum of 3 quarters · filed 2025-08-28 | -$2.16M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$1.67M 10-Q/A · filed 2025-08-28 | -$4.24M derived: sum of 2 quarters · filed 2025-08-28 | $575.00K derived: sum of 3 quarters · filed 2025-08-28 | -$782.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | -$2.56M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $2.25M derived: sum of 2 quarters · filed 2025-08-28 | $891.00K derived: sum of 3 quarters · filed 2025-08-28 | $1.32M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $4.81M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | $3.46M derived: sum of 2 quarters · filed 2025-08-28 | $3.88M 10-Q/A · filed 2025-08-28 | $12.88M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | -$1.36M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$930.00K 10-Q/A · filed 2025-08-28 | $8.06M derived: sum of 3 quarters · filed 2025-08-28 | $9.75M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $427.00K 10-Q/A · filed 2025-08-28 | $9.42M derived: sum of 2 quarters · filed 2025-08-28 | $11.11M derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | $8.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $10.68M derived: sum of 2 quarters · filed 2025-08-28 | $22.82M 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $13.82M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $12.14M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |